CERo Therapeutics Holdings Inc (NASDAQ: CERO) open the trading on Wednesday, with great promise as it jumped 37.62% to $0.20, before settling in for the price of $0.15 at the close. Taking a more long-term approach, CERO posted a 52-week range of $0.06-$12.80.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded 0.00%. This publicly-traded company’s shares outstanding now amounts to $51.35 million, simultaneously with a float of $26.22 million. The organization now has a market capitalization sitting at $41.85 million. At the time of writing, stock’s 50-day Moving Average stood at $0.1237, while the 200-day Moving Average is $0.8948.
CERo Therapeutics Holdings Inc (CERO) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. CERo Therapeutics Holdings Inc’s current insider ownership accounts for 48.94%, in contrast to 4.24% institutional ownership. According to the most recent insider trade that took place on Sep 25 ’24, this organization’s 10% Owner sold 532,486 shares at the rate of 0.10, making the entire transaction reach 55,538 in total value, affecting insider ownership by 21,067,956. Preceding that transaction, on Oct 10 ’24, Company’s 10% Owner sold 3,250,000 for 0.10, making the whole transaction’s value amount to 325,000. This particular insider is now the holder of 22,620,783 in total.
CERo Therapeutics Holdings Inc (CERO) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
CERo Therapeutics Holdings Inc (NASDAQ: CERO) Trading Performance Indicators
Let’s observe the current performance indicators for CERo Therapeutics Holdings Inc (CERO). It’s Quick Ratio in the last reported quarter now stands at 0.39. The Stock has managed to achieve an average true range (ATR) of 0.05.
In the same vein, CERO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.44.
Technical Analysis of CERo Therapeutics Holdings Inc (CERO)
[CERo Therapeutics Holdings Inc, CERO] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 7.55% While, its Average True Range was 0.0620.
Raw Stochastic average of CERo Therapeutics Holdings Inc (CERO) in the period of the previous 100 days is set at 36.11%, which indicates a major rise in contrast to 35.84% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 527.87% that was higher than 239.42% volatility it exhibited in the past 100-days period.
